TransMedics Group Inc (TMDX) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $134.57
• Market Cap: $4.51B
• P/E Ratio: 51.91
• EPS: $2.54
• 52-Week High: $156.00
• 52-Week Low: $62.07

Market Sentiment

TransMedics Group Inc currently has a Bullish sentiment score of 0.43.

About TransMedics Group Inc

TransMedics Group, Inc. (TMDX) is an innovative medical technology company headquartered in Andover, Massachusetts, dedicated to transforming organ transplant therapy for patients with end-stage organ failure. The company has developed the proprietary Organ Care System, which significantly improves the preservation and optimization of donor organs, ultimately enhancing patient outcomes and expanding transplant viability. As a commercial-stage organization, TransMedics is strategically positio...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for TransMedics Group Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TMDX pay dividends?

TransMedics Group Inc (TMDX) does not currently pay a regular dividend.

What is TMDX's P/E ratio?

TransMedics Group Inc has a price-to-earnings (P/E) ratio of 51.91.

What is TMDX's market cap?

TransMedics Group Inc (TMDX) has a market capitalization of $4.51B with a current stock price of $134.57.